Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and safety of telitacicept in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial
PaperCitations, authors & open-access status
Efficacy and safety of telitacicept in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 75 citations, 2023 year and closed oa status.
75
Citations
2023
Year
closed
OA Status